David Ahern
Impact in
- Immunology top 5%
- Atherosclerosis and Cardiovascular Diseases
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
- Immunology 11
- T-cell and B-cell Immunology 5
- Immune Cell Function and Interaction 3
- Atherosclerosis and Cardiovascular Diseases 2
-
- COVID-19 Clinical Research Studies 5
- SARS-CoV-2 and COVID-19 Research 3
- Co-authors
- Fionula M. Brennan (3 shared papers)Kamal D. Puri (1 shared paper)Laura Cubitt (1 shared paper)Felix Clemens Richter (1 shared paper)Alison Simmons (1 shared paper)Hashem Koohy (1 shared paper)Agne Antanaviciute (1 shared paper)François G. Gervais (1 shared paper)
- Journals
- Cell (2 papers)Cardiovascular Research (2 papers)JCI Insight (1 paper)Science Immunology (1 paper)Nature Communications (1 paper)
- Partner nations
- United KingdomGermanyUnited States
In The Last Decade
David Ahern
24 papers receiving 1.6k citations
David Ahern's Hit Papers
Peers
Comparison fields: 5 of 94
- Immunology 379
- Infectious Diseases 205
- Genetics 292
- Rheumatology 94
- Oncology 153
Countries citing papers authored by David Ahern
This map shows the geographic impact of David Ahern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Ahern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Ahern more than expected).
Fields of papers citing papers by David Ahern
This network shows the impact of papers produced by David Ahern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Ahern. The network helps show where David Ahern may publish in the future.
Co-authors
The 25 scholars most cited alongside David Ahern, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Structural Remodeling of the Human Colonic Mesenchyme in Inflammatory Bowel Disease Hit paper breakdown → | 2018 | 562 |
| 2 | A blood atlas of COVID-19 defines hallmarks of disease severity and specificity Hit paper breakdown → | 2022 | 225 |
| 3 | 2018 | 140 | |
| 4 | 2020 | 90 | |
| 5 | 2020 | 81 | |
| 6 | 2020 | 75 | |
| 7 | 2010 | 50 | |
| 8 | 2011 | 46 | |
| 9 | 2021 | 38 | |
| 10 | 2014 | 37 | |
| 11 | 2022 | 35 | |
| 12 | 2023 | 32 | |
| 13 | 2022 | 30 | |
| 14 | 2012 | 26 | |
| 15 | 2021 | 26 | |
| 16 | 2020 | 23 | |
| 17 | 2023 | 21 | |
| 18 | 2009 | 20 | |
| 19 | 2021 | 14 | |
| 20 | 2021 | 13 |
About David Ahern
David Ahern is a scholar working on Immunology, Infectious Diseases, Oncology, Genetics and Hematology, having authored 24 papers that have together received 1.6k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (5 papers), T-cell and B-cell Immunology (5 papers), Immune Cell Function and Interaction (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), Single-cell and spatial transcriptomics (2 papers) and Atherosclerosis and Cardiovascular Diseases (2 papers). The work is most often cited by research in Immunology (379 citations), Infectious Diseases (205 citations), Genetics (292 citations), Rheumatology (94 citations) and Oncology (153 citations). David Ahern has collaborated with scholars based in United Kingdom, Germany and United States. Frequent co-authors include Fionula M. Brennan, Kamal D. Puri, Laura Cubitt, Felix Clemens Richter, Alison Simmons, Hashem Koohy, Agne Antanaviciute, François G. Gervais, Esther Mellado-Gomez and Neil Ashley. Their work appears in journals such as Cell, Cardiovascular Research, JCI Insight, Science Immunology and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.